Lack of recurrent NF2 mutations among our WHO grade 1 meningiomas, as well as in most series reported in the literature, suggests that sporadic meningioma cells frequently acquire NF2 mutations randomly (11), in both WHO grade 1 and higher-grade tumors (9, 12). This evidence concerns the gene NF2 and meningioma.